RETHINK ORTHOPEDICS is a start-up venture in the medical devices sector.
Our developments currently target a market niche valued annually at $400m in a $40 billion global market sector and growing with a sustainable CAGR of 6%.
With development and approval processes for implanted instrumentation being relatively low cost and low risk compared with many other healthcare product domains, the sector offers attractive investment opportunities.
RETHINK ORTHOPEDICS has identified areas where improvements to devices and instruments, the application of new technologies to pre-operative planning and the optimization of in-theatre procedures offer incontestable benefits, both in terms of patient well-being and reduced total cost of care.
Current developments include:
- A new method and instrumentation for treating severe spinal deformities such as scoliosis.
- An improved instrumentation and technique for treating complex pelvic fractures.
- An instrumentation and surgical method for the precise removal of diseased bone affected by Osseous Avascular Necrosis.